Anti-Ro/SSA antibodies and cardiac arrhythmias in the adult: facts and hypotheses.
It is well established that the passive trans-placental passage of anti-Ro/SSA antibodies from mother to foetus is associated with the risk to develop an uncommon syndrome named neonatal lupus (NLE), where the congenital heart block represents the most severe clinical feature. Recent evidence demonstrated that also adult heart, classically considered invulnerable to the anti-Ro/SSA antibodies, may represent a target of the arrhythmogenicity of these autoantibodies. In particular, the prolongation of the QTc interval appears the most frequent abnormality observed in adults with circulating anti-Ro/SSA antibodies, with some data suggesting an association with an increased risk of ventricular arrhythmias, also life threatening. Moreover, even though the association between anti-Ro/SSA antibodies and conduction disturbances is undoubtedly less evident in adults than in infants, from the accurate dissection of the literature data the possibility arises that sometimes also the adult cardiac conduction tissue may be affected by such antibodies. The exact arrhythmogenic mechanisms involved in foetus/newborns and adults, respectively, have not been completely clarified as yet. However, increasing evidence suggests that anti-Ro/SSA antibodies may trigger rhythm disturbances through an inhibiting cross-reaction with several cardiac ionic channels, particularly the calcium channels (L-type and T-type), but also the potassium channel hERG, whose different expression and involvement in the cardiac electrophysiology during lifespan might account for the occurrence of age-related differences.
Lazzerini
P E
PE
Department of Clinical Medicine and Immunological Sciences, Division of Clinical Immunology, University of Siena, Italy. lazzerini7@unisi.it
Capecchi
P L
PL
Laghi-Pasini
F
F
D000328:Adult; D000974:Antibodies, Antinuclear / Q000276:immunology*; D001145:Arrhythmias, Cardiac / Q000209:etiology* / Q000276:immunology*; D006801:Humans; D007473:Ion Channels / Q000276:immunology; D008133:Long QT Syndrome / Q000209:etiology / Q000276:immunology
D000974:Antibodies, Antinuclear; D007473:Ion Channels; C035356:SS-A antibodies